[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Docetaxel Market in Southeast Asia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 94 pages | ID: DA493774CE17EN
Market Monitor Global

US$ 2,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
This report contains market size and forecasts of Docetaxel in Southeast Asia, including the following market information:
Southeast Asia Docetaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
Southeast Asia Docetaxel Market Consumption, 2015-2020, 2021-2026, (K Units)
Southeast Asia Docetaxel Production Capacity, 2015-2020, 2021-2026, (K Units)
Top Five Competitors in Southeast Asia Docetaxel Market 2019 (%)
The global Docetaxel market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Docetaxel market size in Southeast Asia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Docetaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Docetaxel production and consumption in Southeast Asia

Total Market by Segment:

Southeast Asia Docetaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
Southeast Asia Docetaxel Market Segment Percentages, By Type, 2019 (%)
  • 20 mg/ml
  • 40 mg/ml
  • 60 mg/ml
Southeast Asia Docetaxel Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)
Southeast Asia Docetaxel Market Segment Percentages, By Application, 2019 (%)
  • Breast Cancer
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Other
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Docetaxel Market Competitors Revenues in Southeast Asia, by Players 2015-2020 (Estimated), ($ millions)
Total Docetaxel Market Competitors Revenues Share in Southeast Asia, by Players 2019 (%)
Total Southeast Asia Docetaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total Southeast Asia Docetaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
  • Hengrui Medicine
  • Sanofi
  • Qilu Pharma
  • Shenzhen Main Luck Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Docetaxel Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Southeast Asia Docetaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: SOUTHEAST ASIA DOCETAXEL OVERALL MARKET SIZE

2.1 Southeast Asia Docetaxel Market Size: 2020 VS 2026
2.2 Southeast Asia Docetaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 Southeast Asia Docetaxel Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Docetaxel Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Docetaxel Companies Ranked by Revenue
3.3 Southeast Asia Docetaxel Revenue by Companies (including Foreign and Local Companies)
3.4 Southeast Asia Docetaxel Sales by Companies (including Foreign and Local Companies)
3.5 Southeast Asia Docetaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Docetaxel Companies in Southeast Asia, by Revenue in 2019
3.7 Southeast Asia Manufacturers Docetaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Docetaxel Players in Southeast Asia
  3.8.1 List of Southeast Asia Tier 1 Docetaxel Companies
  3.8.2 List of Southeast Asia Tier 2 and Tier 3 Docetaxel Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Southeast Asia Docetaxel Market Size Markets, 2020 & 2026
  4.1.2 20 mg/ml
  4.1.3 40 mg/ml
  4.1.4 60 mg/ml
4.2 By Type - Southeast Asia Docetaxel Revenue & Forecasts
  4.2.1 By Type - Southeast Asia Docetaxel Revenue, 2015-2020
  4.2.2 By Type - Southeast Asia Docetaxel Revenue, 2021-2026
  4.2.3 By Type - Southeast Asia Docetaxel Revenue Market Share, 2015-2026
4.3 By Type - Southeast Asia Docetaxel Sales & Forecasts
  4.3.1 By Type - Southeast Asia Docetaxel Sales, 2015-2020
  4.3.2 By Type - Southeast Asia Docetaxel Sales, 2021-2026
  4.3.3 By Type - Southeast Asia Docetaxel Sales Market Share, 2015-2026
4.4 By Type - Southeast Asia Docetaxel Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Southeast Asia Docetaxel Market Size, 2020 & 2026
  5.1.2 Breast Cancer
  5.1.3 Prostate Cancer
  5.1.4 Non-small Cell Lung Cancer
  5.1.5 Other
5.2 By Application - Southeast Asia Docetaxel Revenue & Forecasts
  5.2.1 By Application - Southeast Asia Docetaxel Revenue, 2015-2020
  5.2.2 By Application - Southeast Asia Docetaxel Revenue, 2021-2026
  5.2.3 By Application - Southeast Asia Docetaxel Revenue Market Share, 2015-2026
5.3 By Application - Southeast Asia Docetaxel Sales & Forecasts
  5.3.1 By Application - Southeast Asia Docetaxel Sales, 2015-2020
  5.3.2 By Application - Southeast Asia Docetaxel Sales, 2021-2026
  5.3.3 By Application - Southeast Asia Docetaxel Sales Market Share, 2015-2026
5.4 By Application - Southeast Asia Docetaxel Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Hengrui Medicine
  6.1.1 Hengrui Medicine Corporate Summary
  6.1.2 Hengrui Medicine Business Overview
  6.1.3 Hengrui Medicine Docetaxel Major Product Offerings
  6.1.4 Hengrui Medicine Sales and Revenue in Southeast Asia (2015-2020)
  6.1.5 Hengrui Medicine Key News
6.2 Sanofi
  6.2.1 Sanofi Corporate Summary
  6.2.2 Sanofi Business Overview
  6.2.3 Sanofi Docetaxel Major Product Offerings
  6.2.4 Sanofi Sales and Revenue in Southeast Asia (2015-2020)
  6.2.5 Sanofi Key News
6.3 Qilu Pharma
  6.3.1 Qilu Pharma Corporate Summary
  6.3.2 Qilu Pharma Business Overview
  6.3.3 Qilu Pharma Docetaxel Major Product Offerings
  6.3.4 Qilu Pharma Sales and Revenue in Southeast Asia (2015-2020)
  6.3.5 Qilu Pharma Key News
6.4 Shenzhen Main Luck Pharma
  6.4.1 Shenzhen Main Luck Pharma Corporate Summary
  6.4.2 Shenzhen Main Luck Pharma Business Overview
  6.4.3 Shenzhen Main Luck Pharma Docetaxel Major Product Offerings
  6.4.4 Shenzhen Main Luck Pharma Sales and Revenue in Southeast Asia (2015-2020)
  6.4.5 Shenzhen Main Luck Pharma Key News
6.5 Jiangsu Aosaikang Pharma
  6.5.1 Jiangsu Aosaikang Pharma Corporate Summary
  6.5.2 Jiangsu Aosaikang Pharma Business Overview
  6.5.3 Jiangsu Aosaikang Pharma Docetaxel Major Product Offerings
  6.5.4 Jiangsu Aosaikang Pharma Sales and Revenue in Southeast Asia (2015-2020)
  6.5.5 Jiangsu Aosaikang Pharma Key News

7 DOCETAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Docetaxel Production Capacity and Value in Southeast Asia, Situation Analysis and Prediction, 2015-2026
  7.1.1 Southeast Asia Docetaxel Production Capacity, 2015-2026
  7.1.2 Southeast Asia Docetaxel Production 2015-2026
  7.1.3 Southeast Asia Docetaxel Production Value 2015-2026
7.2 Key Local Docetaxel Manufacturers in Southeast Asia
  7.2.1 Southeast Asia Key Local Docetaxel Manufacturers Production Capacity
  7.2.2 Southeast Asia Key Local Docetaxel Manufacturers Production
  7.2.3 Southeast Asia Key Local Docetaxel Manufacturers Production Value
  7.2.4 The Proportion of Docetaxel Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
7.3 Docetaxel Export and Import in Southeast Asia
  7.3.1 Southeast Asia Docetaxel Export Market
  7.3.2 Southeast Asia Docetaxel Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Southeast Asia Docetaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON DOCETAXEL SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Docetaxel Distributors and Sales Agents in Southeast Asia

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Docetaxel in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Docetaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Docetaxel Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Docetaxel Sales by Companies, (K Units), 2015-2020
Table 6. Southeast Asia Docetaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Docetaxel Price (2015-2020) (USD/Unit)
Table 8. Southeast Asia Manufacturers Docetaxel Product Type
Table 9. List of Southeast Asia Tier 1 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Docetaxel Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Docetaxel Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Docetaxel Sales in Southeast Asia (K Units), 2015-2020
Table 14. By Type - Docetaxel Sales in Southeast Asia (K Units), 2021-2026
Table 15. By Application - Docetaxel Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Docetaxel Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Docetaxel Sales in Southeast Asia, (K Units), 2015-2020
Table 18. By Application - Docetaxel Sales in Southeast Asia, (K Units), 2021-2026
Table 19. Hengrui Medicine Corporate Summary
Table 20. Hengrui Medicine Docetaxel Product Offerings
Table 21. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Sanofi Corporate Summary
Table 23. Sanofi Docetaxel Product Offerings
Table 24. Sanofi Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Qilu Pharma Corporate Summary
Table 26. Qilu Pharma Docetaxel Product Offerings
Table 27. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Shenzhen Main Luck Pharma Corporate Summary
Table 29. Shenzhen Main Luck Pharma Docetaxel Product Offerings
Table 30. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Jiangsu Aosaikang Pharma Corporate Summary
Table 32. Jiangsu Aosaikang Pharma Docetaxel Product Offerings
Table 33. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Docetaxel Production Capacity (K Units) of Local Manufacturers in Southeast Asia, 2015-2020
Table 35. Docetaxel Production (K Units) of Local Manufacturers in Southeast Asia, 2015-2020
Table 36. Southeast Asia Docetaxel Production Market Share of Local Manufacturers, 2015-2020
Table 37. Docetaxel Production Value (US$, Mn) of Local Manufacturers in Southeast Asia, 2015-2020
Table 38. Southeast Asia Docetaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 39. The Percentage of Docetaxel Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 40. The Percentage of Docetaxel Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 41. Dangeguojia Docetaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 42. Raw Materials and Suppliers
Table 43. Docetaxel Downstream Clients in Southeast Asia
Table 44. Docetaxel Distributors and Sales Agents in Southeast Asia

LIST OF FIGURES

Figure 1. Docetaxel Segment by Type
Figure 2. Docetaxel Segment by Application
Figure 3. Dangeguojia Docetaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Docetaxel Market Size in Southeast Asia, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. Southeast Asia Docetaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Docetaxel Sales in Southeast Asia: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Docetaxel Revenue in 2019
Figure 9. By Type - Southeast Asia Docetaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Southeast Asia Docetaxel Market Share, 2015-2020
Figure 11. By Type - Southeast Asia Docetaxel Market Share, 2020-2026
Figure 12. By Type - Southeast Asia Docetaxel Price (USD/Unit), 2015-2026
Figure 13. By Application - Docetaxel Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 14. By Application - Southeast Asia Docetaxel Market Share, 2015-2020
Figure 15. By Application - Southeast Asia Docetaxel Market Share, 2020-2026
Figure 16. By Application -Southeast Asia Docetaxel Price (USD/Unit), 2015-2026
Figure 17. Southeast Asia Docetaxel Production Capacity (K Units), 2015-2026
Figure 18. Southeast Asia Docetaxel Actual Output (K Units), 2015-2026
Figure 19. Southeast Asia Docetaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Southeast Asia Docetaxel Export Destination, 2019
Figure 21. The Source of Imports of Southeast Asia Docetaxel, 2019
Figure 22. PEST Analysis for Southeast Asia Docetaxel Market in 2020
Figure 23. Docetaxel Market Opportunities & Trends in Southeast Asia
Figure 24. Docetaxel Market Drivers in Southeast Asia
Figure 25. Docetaxel Market Restraints in Southeast Asia
Figure 26. Docetaxel Industry Value Chain


More Publications